Caladrius Biosciences Inc...

NASDAQ: CLBS · Real-Time Price · USD
0.43
-0.08 (-16.05%)
At close: Sep 15, 2022, 6:00 AM

Caladrius Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-24.57M -23.63M -27.47M -26.1M -24.5M -12.22M
Depreciation & Amortization
36K 46K 55K 64K 66K 64K
Stock-Based Compensation
1.53M 1.43M 1.26M 1.81M 1.27M 1.29M
Other Working Capital
-339K -667K -1.44M -12K 1.11M -1.28M
Other Non-Cash Items
2.65M 3.07M 2.88M 2.06M 1.4M 616K
Deferred Income Tax
374K 374K 374K n/a n/a n/a
Change in Working Capital
-357K -1.2M 647K -1.04M 78K -2.31M
Operating Cash Flow
-20.35M -19.91M -22.25M -23.21M -21.69M -12.56M
Capital Expenditures
-295K -120K -120K -66K -66K -18K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
-104.27M -130.41M -179.78M -150.31M -132.36M -110.71M
Sales Maturities Of Investments
155.45M 134.57M 124.94M 79.93M 46M 27.26M
Other Investing Acitivies
-9.94M 60K 60K n/a n/a n/a
Investing Cash Flow
40.94M 4.1M -54.9M -70.44M -86.43M -83.47M
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-182K -189K 85.28M 67.87M 76.97M 86.63M
Financial Cash Flow
-182K -189K 85.28M 85.27M 94.36M 104.03M
Net Cash Flow
20.41M -16M 8.13M -8.38M -13.75M 8M
Free Cash Flow
-20.64M -20.03M -22.36M -23.27M -21.75M -12.57M